CERIVASTATIN: 26 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
26
Total FAERS Reports
1 (3.8%)
Deaths Reported
2
Hospitalizations
26
As Primary/Secondary Suspect
3
Life-Threatening
Jul 24, 2000
FDA Approved
Discontinued
Status
Active Ingredient: CERIVASTATIN SODIUM · FDA Application: 020740 ·
First Report: 1999 · Latest Report: 20250730
What Are the Most Common CERIVASTATIN Side Effects?
#1 Most Reported
Myalgia
9 reports (34.6%)
#2 Most Reported
Drug hypersensitivity
6 reports (23.1%)
#3 Most Reported
Hypertension
5 reports (19.2%)
All CERIVASTATIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Myalgia | 9 | 34.6% | 1 | 1 |
| Drug hypersensitivity | 6 | 23.1% | 0 | 0 |
| Hypertension | 5 | 19.2% | 0 | 0 |
Who Reports CERIVASTATIN Side Effects? Age & Gender Data
Gender: 39.1% female, 60.9% male. Average age: 64.6 years. Most reports from: US. View detailed demographics →
Is CERIVASTATIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 0 |
| 2002 | 1 | 0 | 0 |
| 2006 | 1 | 0 | 0 |
| 2019 | 4 | 0 | 0 |
| 2025 | 1 | 0 | 1 |
What Is CERIVASTATIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 8 |
| Hyperlipidaemia | 5 |
Official FDA Label for CERIVASTATIN
Official prescribing information from the FDA-approved drug label.